Market

Can Sutro Biopharma's $75M Offering Fuel Its Cancer Fight?
Management & Regulatory Can Sutro Biopharma's $75M Offering Fuel Its Cancer Fight?

To escalate the war on cancer, Sutro Biopharma has launched a public offering with the goal of raising $75 million. These proceeds are set to bolster Sutro's efforts in creating cutting-edge antibody-drug conjugates (ADCs), which stand at the forefront of its cancer treatment research. By securing

Navigating the Risks of Meme Stocks: GameStop, Reddit, and Trump Media
Management & Regulatory Navigating the Risks of Meme Stocks: GameStop, Reddit, and Trump Media

The term 'meme stock' has become a staple in the vernacular of everyday investors, describing stocks that gain popularity through social media platforms and online forums. Prominent among these are companies like GameStop, Reddit, and Trump Media, each becoming a centerpiece of retail speculative

Is Biotech the Next Big Boom? Incyte, Jazz, Exelixis Lead
Management & Regulatory Is Biotech the Next Big Boom? Incyte, Jazz, Exelixis Lead

The Biotech Industry Landscape Biotech Innovation and Market Growth The biotech sector is experiencing a remarkable surge, propelled by advances in personalized medicine and increased interest in orphan drugs. Personalized medicine is a game-changer, allowing treatments to be specifically tailored

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later